Mereo BioPharma Group (MREO)

MREO trades at $2.04, 2.0% above the near-term max pain of $2 expiring Oct 17, 2025 (12 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($0.5-$7), signaling increased put positioning or downside protection. Key magnetic zone at 2 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for MREO shows a downward trend from 7 to 0.5, indicating bearish sentiment or hedging activity. The 315% spread signals divergent expectations across timeframes. Most levels below 2.04 may cap rallies. Strong magnetic level at 2 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.